Global Stem Cells Group announces the opening of cell therapy and regenerative medicine center in Indonesia
Global Stem Cells Group is pleased to announce the establishment of a cell therapy and regenerative medicine facility in Indonesia. The new facility emphasizes Global Stem Cell Group’s objectives of bringing the advances and benefits of regenerative medicine to parts of the world where they are less well known.
By enabling cooperation with Dr. Yanti Kusmiran Clinic in Indonesia , this new center will promote high standards of service in Regenerative medicine across Indonesia.
The vision
This center is part of an expanding medical network of partners, and it will formalize and strengthen ties, establishing a global center of excellence to guarantee that we effectively use the underlying basic stem cell technology for medical conditions where traditional therapeutic approaches seem to have failed . This is consistent with the GSCG’s overall strategy for developing regenerative medicine through data-driven studies, disease modeling, and cell-based therapeutics.
There wouldn’t have been a better partner to go sign this deal with, Dr. Yanti Aesthetic Clinic provides the organizational and physical infrastructure needed to disseminate need-based stem cell and gene therapies locally. And Global Stem Cells Group’s outstanding cell and stem cell biology and disease pathophysiology give an edge to any patient they’re prescribed to.
GSCG has developed an enviable reputation in regenerative medicine. So, this presents the perfect opportunity to translate breakthrough therapies from basic discoveries to useful products drawing on the skills and local knowledge of Dr. Yanti Aesthetic Clinics.
Group managing director Benito Novas provided the clearest description of the new strategic direction and GSCG’s objectives. “Our main goal is to make regenerative medicine benefits a reality for both doctors and patients all around the world. The company is expanding and establishing itself as a market leader.”
The current market outlook
Cell therapies are becoming an increasingly effective and safe clinical solution to treat conditions that traditional medicine offers only palliative care. That is why patients all over the world are looking for a natural regenerative alternative without the use of drugs and medicines. . However, its application is still in its early stages. Moves like this one try to reduce the impediments to widespread adoption. This effort will play a significant role in the development of regenerative medicine in Indonesia , allowing for continuous improvement through research and development.
Dr. Yanti Aesthetic Clinics
Dr. Yanti Aesthetic Clinics is a premier cosmetic and aesthetics clinic in Kelapa Gading, Jakarta Utara. Since its inception in 2004 in Surabaya by Dr. Khoe Yanti Khusmiran, the hospital has expanded to over 6 branches throughout Indonesia. They provide a range of skin and body enhancement treatments and stand to gain from stem cell therapies for their minimally invasive and non-invasive procedures.
The newly formed association will deliver revolutionary medicines through these clinics to assist patients in avoiding permanent harm and live healthy lives. Changing the paradigm from asymptomatic treatments to cures that improve quality of life. Dr. Yanti Kushmiran was enthusiastic about this announcement. He said, “We are honored to be a part of GSCG, which has an over 10-year track record in the market and a strong international reputation. We will provide more services to our patients because of this new partnership.”
GSCG delivers leadership in regenerative medicine research, patient applications, and training through our strategic global networks. We endeavor to enable physicians to treat otherwise incurable diseases using stem cell therapy and to improve the quality of life and care across the world.
For this reason, we work with innovative next-generation therapy providers like Dr. Yanti Aesthetic Clinics to give access to one-of-a-kind holistic, and safe, treatment options.
More information regarding this transaction and the Global Stem Cells Group may be found at GSCG.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
- Published in News
ISSCA Members to Present in the XXV Congreso Internacional de Medicina, Cirugia Estética y Obesidad
The XXV Congreso Internacional de Medicina, Cirugia Estética y Obesidad will take place in CDMX, México on July 13,14 and 15, 2022. The International Society for Stem Cell Application (ISSCA) will be actively taking part in the congress. The ISSCA is a multidisciplinary community of physicians and scientists with a mission to advance the science, technology, and practice of regenerative medicine to treat diseases and lessen human suffering through science, technology, and regenerative medicine. Several ISSCA members will be presenting or giving demonstrations on the latest protocols and technologies in regenerative medicine.
- Benito Novas, the managing director of the ISSCA from the USA, will give a talk about Digital Marketing in Cash-Based Practices. Benito Novas is a global entrepreneur, manager, and keynote speaker, who specializes in marketing focused on biotechnology, life sciences, and healthcare development. He has served as the director of the ISSCA since 2016. His published books in Aesthetic Practice and Digital Marketing can be found here. In his presentation this July, he will share his visionary approach to healthcare management and regenerative medicine. Congress attendees will have the opportunity to learn why doctors must use digital marketing strategies to grow a successful practice. Benito Novas will provide tips to attendees on how to capitalize on social media trends to grow practice influence.
- Dr. Maritza Novas, the ISSCA director of education from the USA, will talk about Allogeneic Therapies and Stromal Cell Exosomes. The use of allogeneic therapy is one of the most attractive alternatives to autologous products and is of utmost interest to researchers in recent years. Exosomes serve as mediators for cell-to-cell communication and can be used as cell-free therapeutics for their special characteristics. Dr. Maritza Novas has been in aesthetic and anti-aging medicine since 2001. She is globally recognized for her work in regenerative medicine and dedicated service in education.
- Dr. Silvina Pastrana, the Argentina chapter director of the ISSCA from Argentina, will present on Fundamentals of Cellular Therapies and Mesenchymal Stem Cells (MSC). Dr. Pastrana heads a staff of medical specialists in orthopedics, rheumatology, medical clinic, and cosmetic surgery, performing procedures that incorporate stem cell therapies. She has been serving as a staff surgeon for the Hospital Dr. Prof. Luis Güemes for 21 years.
Besides the above presentations, look forward to sessions in the practical portion of the congress, where the following ISSCA members will show the latest protocols and technologies in regenerative medicine:
- Dr. Julio Ferreira (Argentina), Cosmetic Surgery / Aesthetic Medicine
- Dr. Andrea Lapeire (Argentina), Aesthetic Medicine
- Dr. Maritza Novas (USA), ISSCA Director of Education in the USA
- Dr. Silvina Pastrana (Argentina), Chapter Director of ISSCA in Argentina
The ISSCA members are the leaders in setting standards and promoting excellence in the field of regenerative medicine, related education, certification, research, and publications. The Global Stem Cells Groups (GSCG) is a group of companies, including the ISSCA and other members, dedicated to facilitating stem cell research and medicine. Making the benefits of stem cell medicine a reality for both doctors and patients worldwide is the goal of the GSCG. To learn more, visit our sites at the ISSCA and the GSCG.
- Published in News
Global Stem Cell Group Launches New Lyophilized Exosomes Product
Global Stem Cells Group is on the front line of advanced skin rejuvenation with a newly launched product.
MIAMI LAKES, Fla., April 4, 2022 – Global Stem Cells Group (GSCG) is proud to announce the launch of its new product with new lyophilized exosome technology. Global Stem Cells Group’s new product line includes innovative anti-aging products that can regenerate cells and tissues in the body.
The new product, known as Cellgenic Lyophilized Exosomes, is derived from human umbilical cord mesenchymal stem cells and includes potent growth factors, peptides, coenzymes, minerals, amino acids, vitamins and UV radiation reducing agents for skin revitalization.
This new cutting-edge product is formulated with powerful growth factors to help combat aging skin, environmental damage and loss of elasticity and tone. It has been clinically tested for its effectiveness. This innovative skincare solution is easy to use and does not require any special shipping or storage requirements. It can be used as an add-on treatment with any other Global Stem Cells Group cosmetic products.
The exosome technology involves the freeze-drying of extracellular vesicles (EVs). These EVs are isolated from mesenchymal stem cell cultures that have been expanded in the laboratory. The Lyophilized Exosomes are then reconstituted with saline in front of the patient just before use.
It has been shown that these vesicles contain RNA, proteins and metabolites which promote wound healing, angiogenesis, tissue regeneration and anti-inflammatory effects when applied topically to the skin.
Global Stem Cells Group is on the front line of advanced skin rejuvenation. The company’s new product, Lyophilized Exosome, can be shipped anywhere in the world without refrigeration. This technology is a first for exosome preparation and will revolutionize the way that skin care professionals do business.
With offices in multiple countries around the globe, Global Stem Cells Group has become one of the fast-growing companies in its field. Now, with the launch of a new product, Lyophilized Exosomes, they are poised to continue that growth and solidify their position as a leader in advancing regenerative medicine worldwide.
“Our goal at Global Stem Cells Group is to develop the most effective regenerative products on the market,” said Benito Novas, CEO of Global Stem Cells Group. “Our new product line of lyophilized exosomes is a testament to our commitment to developing cutting edge products with great clinical utility.”
To learn more about Cellgenic Flow Exosomes, visit https://cellgenic.com/.
About Global Stem Cells Group
Global Stem Cells Group is a worldwide network of physicians and scientists dedicated to the advancement of stem cell therapies and regenerative medicine. It has developed a comprehensive stem cell therapy protocol that includes harvesting, processing, banking, and administering adult stem cells. Global Stem Cells Group administers a constant flow of knowledge and innovation regarding the role of stem cells in modern medicine. The company’s aim is to accelerate the process of getting promising stem cell research and technology developed into treatments and therapies, and made available to physicians and patients.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
Media Contact:
Benito Novas
305-560-5337
info@stemcellsgroup.com
- Published in News
ISSCA Partners With Ramzan Ali Syed Hospital to Developing and advancing cellular therapies in Pakistan
First-of-its-kind Cellular Therapy Training for doctors and medical practitioners in Pakistan
Newswise — Miami, FL –March 9th, 2022- The International Society for Stem Cell Applications (ISSCA) and Global Stem Cells Group (GSCG) today announced a new partnership with Ramzan Ali Syed Hospital (RASC) to develop autologous bone marrow stem cell and exosome-based cell therapies and advance new therapeutic options for patients in the region.
“Regenerative medicine is a fast-paced field that is growing exponentially every year as more and more research is being conducted and products are being used in clinics and doctors’ offices worldwide. -Said- Benito Novas Managing director of the International Society for Stem Cell Applications. We are very proud to be able to collaborate with our hosts in Pakistan for the development of this medical specialty”.
To stay abreast of current research, Ramzan Ali Syed Hospital partners with organizations like ISSCA and Global Stem Cells Group to provide continuing education opportunities for the doctors and specialists in Pakistan who want to learn more about how they can incorporate cellular therapies into their practice and help more patients with the latest generation of biologics and regenerative medicine products.
The first physician training course will be held in Lahore, Pakistan on March 30th – 31st & April 1st. Attendees will receive hands-on training on current protocols for MSC’s derived stem cell therapies, Exosomes, Bone Marrow derived stem cells, and PRP treatments as well as information about the most recent clinical applications with cellular medicine.
“This is the first time that ISSCA and Ramzan Ali Syed Hospital join forces for a stem cell certification course in the country, and this partnership will allow for more courses to be held in the future. This collaboration was born out of a desire to bring new technologies and cutting-edge treatments to patients throughout the country”. Said Dr. Mehmood Shaukat, Head of Pediatric Surgery
“With Pakistan’s Ramzan Ali Syed Hospital as the newest member of the ISSCA community, we look forward to strengthening our relationship with the country and offering more support within the region,” said Benito Novas, CEO of the Global Stem Cells Group and Managing Director of ISSCA USA. “We know there is a lot of potential for cell therapies to have a huge impact here. Our goal is always to help patients and doctors have access to the best possible care, no matter where they live.”
Physicians looking to offer regenerative medicine treatments can benefit from the ISSCA and Ramzan Ali Stem Cell Center trainings, which are conveniently held onsite at the Ramzan Ali Syed Hospital, To learn more about the onsite training for doctors and other opportunities offered by ISSCA, visit https://www.issca.us
About ISSCA
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology, and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
About Ramzan Ali Syed Hospital
Ramzan Ali Stem Cell Center is an all-inclusive healthcare facility in regenerative medicine located in the premises of Ramzan Ali Syed Hospital at 21 Temple Road, Lahore, Pakistan. It is a pioneering institution with a passion for the safety of all its patients. We will make sure to give you all the information you require to guide you in making better decisions for your health.
About GSCG
Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
- Published in News
Stem Cell Center Opens Facility in Argentina, Bringing Advanced Health Technology
December 24th, 2021: Stem Cell Center has opened a new location in Córdoba, Argentina. Looking to bring regenerative medicine technologies to Argentina, the grand opening of the center was attended by 80 attendees at the new IMEB facilities, and broadcast for viewers across Argentina and the rest of the world to stream online.
As a division of Global Stem Cells Group, Stem Cell Center is an international network of medical practices dedicated to bringing stem cell therapies to patients across the world. By uniting a group of medical practitioners in the field, they are able to provide training, equipment, and resources to practitioners who in turn offer research and knowledge to the community. As a group, they are continuously developing new treatments, making them available, and bringing the best possible care to patients in the pursuit of stem cell technology.
The launch of the new facility brings the group one step closer to their shared goal of reducing human suffering across the world, now making strides to provide access to these medical technologies in Argentina. Each new launch contributes to the acceleration of the process of developing and translating stem cell research into treatments and therapies that are accessible to both patients and physicians.
“Opening the center in Córdoba is a major step toward that goal, allowing us to give solutions to patients without drugs, instead manifesting the potential that lies within the body itself to trigger biological regeneration processes,” says Benito Novas, Founder of Global Stem Cells Group. This latest opening was made possible by a partnership and alliance between founder of Global Stem Cells Group, Benito Novas, and Director of IMEB, Doctor Luis Alejandro Mazzarini.
“This inauguration marks the launch of the pursuit of regenerative medicine, cell therapy, and tissue engineering treatments in Córdoba,” says Benito Novas. “I founded the group in 2010, as an expert in marketing, life sciences, and healthcare development. At the time, I was interested in the new progress that was being made in the field and was eager to make them available to as wide an array of patients as possible across the world.”
“We believe stem cell medicine is the future of the medical industry, and we work closely with regulators, policymakers, and medical professionals to foster this technology and harness the true potential.”
The seminal launch of this science, research and medical facility is one effort in the global mission of Stem Cell Center, who have announced a partnership with Bioscience Cell factory, offered training in Bolivia, and opened centers in Spain, Mexico, and Iraq. The global effort to reduce suffering is achieved one facility at a time, through the dedication of scientists, doctors, and researchers who believe in the untapped and often inaccessible potential of stem cell regenerative technology.
To learn more about the Stem Cell Center, visit their website here: https://stemcellcenter.net/about/
- Published in News
ISSCA organizes regenerative medicine symposium in alliance with IMEB in Córdoba, Argentina
The World Symposium on Stem Cells and Regenerative Medicine attracted a notable global audience interested in exploring the latest trends in regenerative medicine
MIAMI LAKES, Florida (December 22, 2021)—The International Society for Stem Cell Application (ISSCA), a multidisciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and regenerative medicine, recently hosted a two-day symposium in Córdoba, Argentina. Held on December 10-11, 2021, the symposium featured onsite and virtual attendance options, attracting a large global swath of physicians, medical specialists, surgeons, dentists, veterinarians, and other professionals interested in regenerative medicine.
ISSCA hosted the event in conjunction with the support of the Argentine Society of Biological and Holistic Medicine (SAMByH) and the Global Stem Cells Group at the facilities of the Institute of Evolutionary and Biological Medicine (IMEB) in Río Cuarto. Eighty attendees were invited to attend the onsite symposium, while hundreds of additional attendees across the globe joined in virtually.
The symposium featured a number of notable experts across the world sharing their insight and expertise on various emerging topics and trends in regenerative medicine. Topics included general cell biology concepts, treatment of various diseases and conditions using regenerative medicine, uses of regenerative practices in aesthetic medicine, and more. Attendees were able to gain additional insight through question-and-answer panels with symposium presenters. Throughout the two-day event, attendees also enjoyed networking opportunities.
“The ISSCA is pleased to have collaborated with SAMByH and IMEB to bring the World Symposium on Stem Cells and Regenerative Medicine to the world. It was a resounding success, and we are thrilled that attendees took away valuable insight into the current state of and future projections for the world of regenerative medicine,” said Benito Novas, ISSCA Director. “Our goal is to help physicians and practitioners better treat their patients suffering from degenerative diseases by giving them the tools and education they need to implement regenerative protocols in their own practices. Our latest symposium has done just that, furthering the advancement of attendees’ knowledge and interest in the field as a viable treatment protocol for their patients.”
“We are thrilled to have collaborated with the ISSCA in bringing this symposium to life,” said Dr. Alejandro Mazzarini, Director of IMEB. “It was exciting to share our facility and the important work we’re doing at IMEB with the world and have such a high caliber of attendees join us for this important event.”
To learn more about the ISSCA’s latest news and innovations, visit https://www.issca.us/.
About ISSCA
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology, and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
- Published in News
Does Stem Cell Therapy Help With Osteoarthritis?
FRIDAY, 24 SEPTEMBER 2021 / PUBLISHED IN BLOG
Overview
Joint pain is one of the most common complaints in medicine. It is more prevalent in seniors whose joints have been subject to long-term wear and tear.
Many people develop conditions like osteoarthritis (OA) and rheumatoid arthritis (RA). The former is more common in women.
Although the pain may be temporary, it can also last for months or even years. For this reason, researchers suggested stem cell therapy to address joint disorders.
In this article, we will discuss how stem cell therapy can be useful in treating joint conditions such as osteoarthritis.
Knee Pain: What Can I Do?
Stem Cell Therapy and Arthritis
According to the Centers for Disease Control and Prevention, 54.4 million Americans (22.7%) suffered from arthritis during 2013–2015.
The number is likely to be underestimated because people don’t always seek medical attention. Instead, they prefer to use home remedies to soothe the pain.
These statistics are still extremely troubling because of the poor functional prognosis associated with arthritis.
Once you get diagnosed with arthritis, several treatments could be prescribed, including acetaminophen – it is generally the first-line treatment.
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) are the second. These include naproxen, diclofenac, and ibuprofen.
Side effects of NSAIDs include:
- Stomach ulcers
- Mineral deficiencies
- Increased bleeding risk
Corticosteroids (e.g., prednisone) are another alternative to NSAIDs. These drugs get used when NSAIDs fail to work. Side effects of drugs such as prednisone can be very serious, presenting as:
- Cushing syndrome
- High blood sugar
- Osteoporosis
- Immunosuppression
Non-pharmacological treatments such as cryotherapy or thermotherapy are the final options for treating joint problems.
How Can Cell Therapy Help With Arthritis?
Many treatment options for joint disorders can cause serious side effects, which may be more severe than the original symptoms. Therefore, scientists are always looking for alternative therapies that could help patients without causing an array of side effects.
Enter: Stem Cell Therapy
Patients with osteoarthritis often undergo joints tissue degeneration. Their articulations start to lack structural elements, including bone, cartilage, and ligaments. From this concept, the idea of using stem cell therapy to treat arthritis originated.
Because stem cells have the ability to differentiate into any cell type, they could replace the lost tissue and help restore joint function.
While this treatment may not cure all joint disorders, it is still a viable option that should be discussed. The need for stem cell therapy becomes more pronounced when your symptoms do not respond to conventional therapies.
The best part about stem cell therapy is its side effect profile. Unlike other treatments, stem cell therapy barely causes any adverse effects. In other words, it is completely safe to use on almost everyone.
Here you can check more information about Osteoarthritis and our treatments: Osteoarthritis Treatments
Takeaway Message
Many medical institutions are now incorporating stem cell therapy in their treatment plans. Orthopedic surgery is one of the most popular.
Hopefully, the use of stem cell therapy will become more mainstream to help as many patients as possible.
If you want to learn more about stem cell therapy, please do not hesitate to check out this link: Stem Cell Therapy
- Published in Blog
The Potential Benefits of Stem Cells for Concussions – What You Need To Know (2021)
THURSDAY, 23 SEPTEMBER 2021 / PUBLISHED IN BLOG
Overview
Traumatic brain injuries (TBI), also known as concussions, are among the most frequent causes of death in the United States.
According to the Centers for Disease Control and Prevention (CDC), the number of emergency department visits related to TBI admissions, complications, and deaths increased by 53% in recent years.
People who can recover from TBI may experience irreversible neurological issues throughout their lives. As a result, they lose their autonomy and become reliant on other people to perform daily activities.
However, it’s not all doom and gloom. A few studies suggest that stem cell therapy could be beneficial in the management of TBI.
In this article, we’ll discuss everything you need to know about the potential effects of stem cell therapy in managing concussions.
How Can Stem Cells Help With Concussions?
For those unfamiliar with how stem cells function, here is a short description:
Stem cells can develop into any kind of tissue or cell, including those that don’t typically regenerate (e.g., heart cells, nerve cells). For instance, medical schools often teach that a person has the same number of neurons from the moment they are born to their death.
Although this assertion is not completely true due to the latest evidence that supports the ability of neurons to regenerate, the rate of regeneration is nowhere near enough to restore the damaged tissues caused by TBI or strokes.
To this end, researchers are using stem cells to create new neurons to help patients with TBI, multiple sclerosis, and other neurological disorders.
What is the Scientific Consensus on Stem Cell Therapy and Traumatic Brain Injuries?
Mesenchymal stem cells derived from the bone marrow, umbilical cord, or adipose tissues showed positive results in the management of concussions.
In a number of studies, the administration of stem cell therapy via the spinal cord showed real evidence of lesion improvement. Researchers used advanced imaging techniques such as functional MRI to objectify the changes.
Neuroscientists theorize that stem cells can replace the dead neurons, which helps with restoring some of the lost functions.
Today, hundreds of clinical trials are trying to unveil the full extent of how stem cell therapy helps with traumatic brain injuries.
Based on the available research, scientists advocate for the use of stem cell therapy in treating patients with severe concussions.
However, neuroscientists insist that stem cell therapy is only used in patients who failed to respond to conventional treatment methods.
Are You a Candidate for Stem Cell Therapy?
To see whether you are a candidate for stem cell therapy, contact us by clicking on this link. You will speak with one of our healthcare professionals in Cancun, México.
Takeaway Message
Stem cells have an amazing ability to divide into any type of tissue and potentially restore lost functions.
We hope that this article managed to highlight the potential role of stem cell therapy in addressing traumatic brain injury.
If you have any questions or concerns regarding stem cell therapy or TBI, please do not hesitate to share your thoughts in the comment section below.
- Published in Blog
Can Stem Cell Therapy Help With Alopecia (hair loss)?
THURSDAY, 23 SEPTEMBER 2021 / PUBLISHED IN BLOG
Overview
Despite the impressive advancements made in the field of medicine, hair loss remains unsolved today.
Every year, hundreds of clinical trials attempt to come up with a revolutionary treatment that will restore hair loss. Unfortunately, most of these studies fail to produce sufficient results.
Interestingly, the issue with hair loss is not financial. In other words, the scientific community spent billions of dollars to find a solution for this problem. This is not the case for other dermatological conditions (e.g., rosacea).
In this article, we will briefly cover the downsides of hair loss, then switch gears to the potential effects of stem cell therapy in addressing this issue.
The Downsides of Hair Loss
While unaffected people see hair loss as a mere esthetic issue, patients with this condition experience many adverse effects, including mental health problems, such as depression, low self-esteem, and a high sense of self-consciousness.
These issues could negatively impact the quality of life of these patients.
Moreover, alopecia affects both genders in great numbers, making this a real public health issue. We should note that some cases of hair loss have underlying conditions, such as hypothyroidism, autoimmune diseases, and infections.
Stem Cell Therapy and Hair Loss
In recent years, the clinical uses of stem cell therapy have expanded, covering many fields in medicine, such as hair loss.
The primary issue with treating chronic illnesses is their irreversible nature. In other words, once the tissue is lost, there is no effective medication that can recover it.
For instance, when the cells responsible for producing hair follicles die, no drug will be able to restore them.
This is the core issue with alopecia.
Fortunately, biological treatments such as stem cell therapy and exosome therapy might just be the solution to this issue. Due to the incredible ability of stem cells to differentiate into any cell type, they could replace the cells responsible for producing hair follicles.
Typically, your doctor will extract stem cells from your own bone marrow or adipocytes (i.e., fat cells) to prevent any immunological reactions.
Using all of this information, some clinics started offering stem cell therapy to manage hair loss, using noninvasive procedures.
Usually, your doctor will schedule several sessions in order for the results to become apparent. However, many patients report positive findings after the very first therapeutic session.
The Potential of Stem Cell Therapy in Dermatology
Despite the underexploited nature of stem cell therapy, it may potentially help with numerous medical fields, including dermatology and esthetic medicine.
Takeaway Message
Hair loss is a real issue for people from all across the world. Treating this disorder is really challenging, especially when the underlying condition is unclear. Fortunately, stem cell therapy may play an important role in addressing this issue since it’s one of the few therapeutic modalities that actually restore lost tissue.
We hope that this article helped you appreciate the role of stem cell therapy in the management of alopecia.
If you want to become a specialist in stem cell therapies and help your patients, check our next training dates here: Exosomas + PRP The healing combo – Cellular Hope Institute – Cancún, México
- Published in Blog
Wharton’s Jelly injection
MONDAY, 20 SEPTEMBER 2021 / PUBLISHED IN BLOG
What is Wharton’s Jelly?
Wharton’s Jelly is the gelatinous connective tissue found in the umbilical cord. This once discarded substance, previously thought of as afterbirth waste, is rich in healing substances and abundant in mesenchymal stem cells (MSCs).
Benefits of Mesenchymal Stem Cells from Wharton’s Jelly
The mesenchymal stem cells in Wharton’s Jelly are special because they are not readily recognized by the body’s immune system. They are considered “primitive cells,” meaning they have properties similar to embryonic cells. This reduces the risk of an immune reaction when these cells are injected into a patient.
Minimally processed Wharton’s Jelly preserves the growth factors and proteins needed for effective healing.
Who Can Benefit from Wharton’s Jelly Treatment?
Wharton’s Jelly is used in regenerative medicine, which employs naturally occurring cells and substances to promote tissue regeneration and healthy cell growth. This natural substance contains collagen, anti-inflammatory properties, growth proteins, and hyaluronic acid.
Treatment with Wharton’s Jelly can help with various ailments, including:
- Degenerative diseases
- Osteoarthritis
- Ligament and muscle damage
- Joint pain and inflammation
- Chronic pain
- Wound healing
There are no age restrictions on who can receive this treatment, and often a patient will only need treatment once.
How Does Wharton’s Jelly Treatment Work?
A specialized, minimally processed product derived from Wharton’s Jelly is injected into the injured site. While numbing is not always needed, lidocaine may be used for particularly sensitive areas. This process involves a relatively painless pinch of a needle. Once injected, the mesenchymal stem cells begin to transform into the cells needed to regenerate damaged tissue, reducing inflammation and pain, and restoring functionality.
Are There Any Side Effects to the Treatment?
No long-term risks or side effects have been reported. It is important to discuss proper protocols with your doctor before treatment.
Reasons to Undergo Cellular Therapy in Cancun, Mexico with Us
One of the main advantages of receiving cellular therapy treatment in Mexico is the ability to cultivate and reproduce, in a laboratory environment, the cells extracted from patients. This means a patient can receive a much larger concentration of cells, leading to improved results.
Additionally, Mexico is a great option for treatments that require a more invasive approach—a larger operating team, more medical products, and PPE. As one of the Western Hemisphere’s largest medical tourism capitals, treatments in Mexico are performed in hospitals that comply with FDA regulations and are offered at a more affordable price point.
While these treatments require a large investment from the patient, the cost of a multiple-day cellular therapy treatment in Mexico is far more affordable than the same treatment in the United States and Canada, especially without the ability to use culture-expanded cells.
What is the Recovery Period?
The actual injection does not require a recovery period, and most patients can return to their normal daily activities immediately. In cases of injury to ligaments or joints, rest may be required. Please follow your doctor’s advice for the best results from treatment.
Overall, Wharton’s Jelly injection treatment is minimally invasive and can help with a variety of ailments. With its limited side effects and regenerative properties, it is safe for patients of any age.
Contact Us
Talk with us to see if Wharton’s Jelly injection therapy is the right fit for you: Click here
About Cellular Hope Institute
At Cellular Hope Institute, we evaluate, diagnose, and treat patients around the world on a daily basis with the latest regenerative medicine modalities available today.
- Published in Blog
